Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinomaRory M. Bade, Joshua M. Lang, Jennifer L. Schehr et al.|Molecular Oncology|2021Cited by 24
46Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC)Bradley A. McGregor, Robert J. Motzer, Philippe Barthélémy et al.|The Oncologist|2025Cited by 0